by Kim Junghyun
SEOUL, June 8 (Xinhua) — The human papillomavirus (HPV) vaccine, though a bit of a tongue-twister, has been one of the latest buzzwords for South Korean obstetricians and gynecologists.
Many of them have lately jumped on the global bandwagon of promoting the HPV vaccines designed to protect women against certain strains of the virus commonly associated with cervical cancer, the second leading cause of cancer-related death for South Korean women.
The Korea Association of Obstetricians and Gynecologists (KAOG), most noticeably, has been banging the drum for the two HPV vaccines currently on the market, Gardasil by Merck Sharp & Dohme and Cervarix by GlaxoSmithKline Biologicals. Since they were introduced to South Korea in September 2007, promotional pamphlets and banners warning of cervical cancer and encouraging vaccination have become a common sight at many local clinics here.